BIOLASE (BIOL) Competitors $0.0074 -0.01 (-50.67%) (As of 12/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends BIOL vs. SONX, DYNT, IONM, SDCCQ, GMVDF, VRAYQ, AHPI, NMRD, MOTS, and BRSHShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Sonendo (SONX), Dynatronics (DYNT), Assure (IONM), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), and Bruush Oral Care (BRSH). These companies are all part of the "medical equipment" industry. BIOLASE vs. Sonendo Dynatronics Assure SmileDirectClub G Medical Innovations ViewRay Allied Healthcare Products Nemaura Medical Motus GI Bruush Oral Care BIOLASE (NASDAQ:BIOL) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, community ranking, media sentiment, dividends, institutional ownership, valuation and profitability. Does the MarketBeat Community prefer BIOL or SONX? BIOLASE received 281 more outperform votes than Sonendo when rated by MarketBeat users. Likewise, 52.80% of users gave BIOLASE an outperform vote while only 40.74% of users gave Sonendo an outperform vote. CompanyUnderperformOutperformBIOLASEOutperform Votes29252.80% Underperform Votes26147.20% SonendoOutperform Votes1140.74% Underperform Votes1659.26% Which has more volatility and risk, BIOL or SONX? BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Sonendo has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Is BIOL or SONX more profitable? BIOLASE has a net margin of -41.65% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets BIOLASE-41.65% -1,782.73% -55.31% Sonendo -92.74%-184.01%-68.60% Which has higher earnings and valuation, BIOL or SONX? BIOLASE has higher revenue and earnings than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBIOLASE$48.83M0.01-$20.63M-$14.940.00Sonendo$44.40M0.02-$60.92M-$69.77-0.03 Do analysts recommend BIOL or SONX? BIOLASE currently has a consensus price target of $1.20, suggesting a potential upside of 16,116.22%. Given BIOLASE's stronger consensus rating and higher possible upside, equities research analysts plainly believe BIOLASE is more favorable than Sonendo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIOLASE 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Sonendo 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of BIOL or SONX? 8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by insiders. Comparatively, 7.9% of Sonendo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer BIOL or SONX? In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score. Company Overall Sentiment BIOLASE Neutral Sonendo Neutral SummaryBIOLASE beats Sonendo on 11 of the 16 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$247,000.00$3.80B$5.12B$9.07BDividend YieldN/A1.74%4.91%4.22%P/E Ratio0.0036.7891.3417.19Price / Sales0.011.511,116.63116.80Price / CashN/A11.1942.5837.86Price / Book-0.111.054.794.78Net Income-$20.63M-$33.08M$120.07M$225.60M7 Day PerformanceN/A-0.60%-1.90%-1.24%1 Month PerformanceN/A-1.91%11.43%3.06%1 Year PerformanceN/A115.25%30.59%16.50% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE0.6587 of 5 stars$0.01-50.7%$1.20+16,116.2%-99.3%$247,000.00$48.83M0.00160SONXSonendoN/A$2.08+4.1%N/A+1,660.0%$894,000.00$43.87M-0.03250Gap UpDYNTDynatronicsN/A$0.12-12.7%N/A-76.0%$871,000.00$33.60M-0.14200Analyst ForecastGap DownIONMAssureN/A$0.04-23.5%N/A-99.0%$141,000.00$149,000.000.00130Gap DownSDCCQSmileDirectClubN/A$0.00-50.0%N/A-96.9%$40,000.00$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/AN/AN/AN/A$26,000.00$4.42M0.0072VRAYQViewRayN/A$0.00+9,900.0%N/AN/A$18,000.00$102.21M0.00300Gap UpHigh Trading VolumeAHPIAllied Healthcare ProductsN/A$0.00+∞N/AN/A$16,000.00$27.05M0.00150News CoverageGap UpNMRDNemaura Medical1.3636 of 5 starsN/AN/A-99.9%$8,000.00$3,017.000.0040Positive NewsMOTSMotus GIN/A$0.00+50.0%N/A-100.0%$2,000.00$319,000.000.0030BRSHBruush Oral CareN/A$0.00flatN/A-99.4%$1,000.00$2.92M0.0011 Related Companies and Tools Related Companies Sonendo Alternatives Dynatronics Alternatives Assure Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives ViewRay Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Bruush Oral Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIOL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOL Stock Alerts